Rice Hall James & Associates’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
Rice Hall James & Associates's EXEL Position: Q2 2026 in Review
Rice Hall James & Associates reduced its Exelixis (EXEL) stake by 34% in Q2 2026, selling an estimated $283K and leaving 11,023 shares worth $600K. The position accounts for 0.03% of the portfolio, ranked #210.
Rice Hall James & Associates first reported a position in EXEL in Q3 2019 and has held it in 28 quarters since. The position peaked at $3.02M in Q2 2020. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.
- Rice Hall James & Associates held 11,023 shares of Exelixis worth $600K as of Q2 2026.
- Rice Hall James & Associates sold 5,803 Exelixis shares in Q2 2026, an estimated $283K.
- Exelixis made up 0.03% of Rice Hall James & Associates's portfolio in Q2 2026, its #210 holding.
- Rice Hall James & Associates first reported a position in Exelixis in Q3 2019 and has held it in 28 quarters since.
- Rice Hall James & Associates's Exelixis position peaked at $3.02M in Q2 2020.
- 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.
Based on Rice Hall James & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.